CA94947L1022
CA94947L1022
WELL HEALTH TECHNOLOGIES CORP
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.06B EUR | 1.06B EUR | 981.15M EUR | 1.01B EUR |
Enterprise Value | 2.06B EUR | 1.76B EUR | 1.52B EUR | 1.48B EUR |
Valuation Multiples | ||||
Trailing P/E | 207x | -- | 43.3x | -- |
Forward P/E | 11.32x | -- | -- | -- |
Price to Sales | 0.7x | 0.92x | 0.88x | 0.98x |
Price to Book | 1.28x | 1.28x | 1.13x | 1.17x |
EV/Revenue | 1.36x | 1.52x | 1.37x | 1.43x |
EV/EBITDA | 11.79x | 10.16x | 8.03x | 8.46x |
Price to FCF (P/FCF) | 640.4x | 15.25x | 15.41x | 13.55x |
EV/FCF | 1,243.57x | 25.29x | 23.88x | 19.79x |
FCF Yield | 0.16% | 6.56% | 6.49% | 7.38% |